search
Back to results

Telemedicine Program in Parkinson's Disease (TELEPARK) (TELEPARK)

Primary Purpose

Parkinson's Disease

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Comprehensive evaluation
Physical Intervention at home
Home-Based telemedicine program
Sponsored by
Fondazione Salvatore Maugeri
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Parkinson's Disease

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 30 patients affected by Parkinson's disease (PD), according to the United Kingdom Parkinson's Disease Society Brain Bank Criteria (Hughes et al.,1992), will be consecutively screened. Participants should have a Hoehn & Yahr stage between 1,5 and 3. All subjects will be on stabilized treatment with L-dopa or dopamine agonists.

All participants will provide written informed consent to the study.

Exclusion Criteria:

  • inability to participate in the exercise programs, other neurological conditions in addition to PD, psychiatric complications or personality disorders, musculoskeletal or cardiopulmonary conditions affecting mobility, and non-consent to participate in the study A cognitive impairment scores measured with Mini Mental State Examination (MMSE) ≤ 26/30.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Participants Telemedicine Care (PTE)

    Participants Usual Care (PUC)

    Arm Description

    A. Comprehensive evaluation at baseline (T0) and at the end of the study (T1). B. Physical Intervention at home for 60 minutes 3 days/week for three months C. Home-Based telemedicine program:

    A. Comprehensive evaluation at baseline (T0) and at the end of the study (T1). B. Physical Intervention at home for 60 minutes 3 days/week for three months

    Outcomes

    Primary Outcome Measures

    Percentage of participants in the PTE group who will concluded the home-based program.
    The program is feasible if at least 80% of participants in the PTE group complete the home program lasting 3 months. The participant completes the home program if carries out at least 50% of the prescribed physical activity.

    Secondary Outcome Measures

    Improvement of quality of life (QoL) measured by the "Parkinson's disease questionnaire" (PDQ-39)
    The PDQ consider eight discrete scales on mobility (10 items), activities of daily living (6 items), emotional well-being (6 items), stigma (4 items), social support (3 items), cognitions (4 items), communication (3 items) and bodily discomfort (3 items). Participants are asked to indicate the frequency of each event by selecting one of 5 options (from never to always). Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better QoL
    Improvement of exercise tolerance capacity measured in the meters walked, by the 6-min walk test (6MWT)
    Improvement of balance measured by Balance Evaluation Systems Test (Mini BesTest)
    The Mini-BESTest includes 14 items representing four domains of dynamic balance:anticipatory postural adjustments (items 1-3), postural responses (items 4-6), sensory orientation (items 7-9) and balance during gait (items 10-14). The Mini-BESTest items are rated on a 3-point scale from 0 to 2 and the total score ranges from 0 to 28 with a higher score indicating better balance performance.

    Full Information

    First Posted
    July 1, 2016
    Last Updated
    July 8, 2016
    Sponsor
    Fondazione Salvatore Maugeri
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02827812
    Brief Title
    Telemedicine Program in Parkinson's Disease (TELEPARK)
    Acronym
    TELEPARK
    Official Title
    Home-Based Telesurveillance and Rehabilitation Program in Parkinson's Disease: Pilot Randomized Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    June 2016 (undefined)
    Primary Completion Date
    May 2017 (Anticipated)
    Study Completion Date
    July 2017 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Fondazione Salvatore Maugeri

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Parkinson's disease (PD) is a chronic neurodegenerative disease due to the loss of dopaminergic neurons in the substantia nigra, leading to motor symptoms of tremor, rigidity, and bradykinesia, as well as an array of non-motor symptoms that affect cognition, sleep, behaviour, and the autonomic nervous system. Lifelong rehabilitation measures, along with medication treatment, are the major components of patient management. Physical exercises positively affect patients' quality of life (QOL) and their functional capacities. Poor adherence to rehabilitation, limited patient education, and access to specialized care can be barriers to treatment. A number of papers in fact report that telemedicine is an acceptable means of care delivery reduces travel burdens and may improve patient outcomes. However, most of these studies were not randomized or controlled and did not include nursing home patients, who may benefit the most from specialty care. Moreover, there is no evidence supporting the use of telerehabilitation for physical assessments of people with PD. For this reason investigators hypothesize that a home telerehabilitation system guiding patients in following their exercise program combined with a computerized decision-support tool monitoring patient performance, would be feasible for and acceptable to patients with PD and would improve functional status.
    Detailed Description
    Aim of the study: Demonstrate the feasibility of at home telesurveillance and rehabilitation program Demonstrate the effectiveness of the program in improving quality of life and functional aspects in patients affected by Parkinson's disease 30 patients affected by Parkinson's disease (PD), will be consecutively screened. The method of sequence generation relied on a computerized random number generator. The person who allocated patients to the two groups was not involved either in treatment or in evaluation of the patients. The study was submitted for approval of the Central Ethics Review Board. Participants will be randomly assigned to two different groups of training using a random number table to receive either telemedicine care (PTE) or their usual care (PUC). All the patients will receive in our Institute a comprehensive baseline evaluation conducted by both the neurologist and the physical therapist specialized in the treatment of PD. During the baseline evaluation (T0), both PTE and PUC will perform two supervised familiarization sessions using the same training protocol to be used once at home. Caregivers are an essential part in the PD patients' home management and rehabilitation and they therefore will be involved in all educational stages. Each patient of both groups will receive two types of physical intervention: A traditional custom-tailored rehabilitative exercise program; he will be trained by the therapist on how to perform the exercises. These exercises will include functional strengthening, stretching, postural changes and balance activities An aerobic training All patients will be asked to perform these exercises for 60 minutes 3 days/week for three months. The training phase will last 20 minutes during the first month and 30 minutes over the second and third month; Training intensity could be progressively increased over the three months of intervention, Aerobic training familiarization sessions will be performed on the same ergometer they will receive for home-based training.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Parkinson's Disease

    7. Study Design

    Primary Purpose
    Health Services Research
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Participants Telemedicine Care (PTE)
    Arm Type
    Experimental
    Arm Description
    A. Comprehensive evaluation at baseline (T0) and at the end of the study (T1). B. Physical Intervention at home for 60 minutes 3 days/week for three months C. Home-Based telemedicine program:
    Arm Title
    Participants Usual Care (PUC)
    Arm Type
    Active Comparator
    Arm Description
    A. Comprehensive evaluation at baseline (T0) and at the end of the study (T1). B. Physical Intervention at home for 60 minutes 3 days/week for three months
    Intervention Type
    Other
    Intervention Name(s)
    Comprehensive evaluation
    Intervention Description
    At baseline (T0) and after 3-months (T1) all patients will be evaluated with Scales and questionnaire.
    Intervention Type
    Other
    Intervention Name(s)
    Physical Intervention at home
    Intervention Description
    A traditional custom-tailored rehabilitative exercise program. The exercises will include functional strengthening, stretching, postural changes and balance activities; - An aerobic training on a cycle ergometer 3 days /week for three months.
    Intervention Type
    Other
    Intervention Name(s)
    Home-Based telemedicine program
    Intervention Description
    A nurse-tutor will follow patients through structured telephone appointments, collecting information about disease status and symptoms, offering advice regarding diet, lifestyle and medications and suggesting changes in therapy, according with the neurologist. The patient's clinical data and any suggestions made will be filled in a personal health electronic record. A physiotherapist-tutor will supervise the patient's home-based individualized rehabilitation program, through scheduled videoconferences.
    Primary Outcome Measure Information:
    Title
    Percentage of participants in the PTE group who will concluded the home-based program.
    Description
    The program is feasible if at least 80% of participants in the PTE group complete the home program lasting 3 months. The participant completes the home program if carries out at least 50% of the prescribed physical activity.
    Time Frame
    Through study completion, an average of 3 months
    Secondary Outcome Measure Information:
    Title
    Improvement of quality of life (QoL) measured by the "Parkinson's disease questionnaire" (PDQ-39)
    Description
    The PDQ consider eight discrete scales on mobility (10 items), activities of daily living (6 items), emotional well-being (6 items), stigma (4 items), social support (3 items), cognitions (4 items), communication (3 items) and bodily discomfort (3 items). Participants are asked to indicate the frequency of each event by selecting one of 5 options (from never to always). Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better QoL
    Time Frame
    Difference between two groups of PDQ-39 measured at baseline (T0) and after 3 months (T1)
    Title
    Improvement of exercise tolerance capacity measured in the meters walked, by the 6-min walk test (6MWT)
    Time Frame
    Difference between two groups of 6MWT measured at baseline (T0) and after 3 months (T1)
    Title
    Improvement of balance measured by Balance Evaluation Systems Test (Mini BesTest)
    Description
    The Mini-BESTest includes 14 items representing four domains of dynamic balance:anticipatory postural adjustments (items 1-3), postural responses (items 4-6), sensory orientation (items 7-9) and balance during gait (items 10-14). The Mini-BESTest items are rated on a 3-point scale from 0 to 2 and the total score ranges from 0 to 28 with a higher score indicating better balance performance.
    Time Frame
    Difference between two groups of Mini BesTest measured at baseline (T0) and after 3 months (T1)

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: 30 patients affected by Parkinson's disease (PD), according to the United Kingdom Parkinson's Disease Society Brain Bank Criteria (Hughes et al.,1992), will be consecutively screened. Participants should have a Hoehn & Yahr stage between 1,5 and 3. All subjects will be on stabilized treatment with L-dopa or dopamine agonists. All participants will provide written informed consent to the study. Exclusion Criteria: inability to participate in the exercise programs, other neurological conditions in addition to PD, psychiatric complications or personality disorders, musculoskeletal or cardiopulmonary conditions affecting mobility, and non-consent to participate in the study A cognitive impairment scores measured with Mini Mental State Examination (MMSE) ≤ 26/30.

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    17724293
    Citation
    Schwab S, Vatankhah B, Kukla C, Hauchwitz M, Bogdahn U, Furst A, Audebert HJ, Horn M; TEMPiS Group. Long-term outcome after thrombolysis in telemedical stroke care. Neurology. 2007 Aug 28;69(9):898-903. doi: 10.1212/01.wnl.0000269671.08423.14.
    Results Reference
    result
    PubMed Identifier
    23599353
    Citation
    Scalvini S, Zanelli E, Comini L, Dalla Tomba M, Troise G, Febo O, Giordano A. Home-based versus in-hospital cardiac rehabilitation after cardiac surgery: a nonrandomized controlled study. Phys Ther. 2013 Aug;93(8):1073-83. doi: 10.2522/ptj.20120212. Epub 2013 Apr 18.
    Results Reference
    result
    PubMed Identifier
    8341308
    Citation
    Hubble JP, Pahwa R, Michalek DK, Thomas C, Koller WC. Interactive video conferencing: a means of providing interim care to Parkinson's disease patients. Mov Disord. 1993 Jul;8(3):380-2. doi: 10.1002/mds.870080326.
    Results Reference
    result
    PubMed Identifier
    16438773
    Citation
    Samii A, Ryan-Dykes P, Tsukuda RA, Zink C, Franks R, Nichol WP. Telemedicine for delivery of health care in Parkinson's disease. J Telemed Telecare. 2006;12(1):16-8. doi: 10.1258/135763306775321371.
    Results Reference
    result
    PubMed Identifier
    19353687
    Citation
    Biglan KM, Voss TS, Deuel LM, Miller D, Eason S, Fagnano M, George BP, Appler A, Polanowicz J, Viti L, Smith S, Joseph A, Dorsey ER. Telemedicine for the care of nursing home residents with Parkinson's disease. Mov Disord. 2009 May 15;24(7):1073-6. doi: 10.1002/mds.22498.
    Results Reference
    result
    PubMed Identifier
    26684265
    Citation
    Arcolin I, Pisano F, Delconte C, Godi M, Schieppati M, Mezzani A, Picco D, Grasso M, Nardone A. Intensive cycle ergometer training improves gait speed and endurance in patients with Parkinson's disease: A comparison with treadmill training. Restor Neurol Neurosci. 2016;34(1):125-38. doi: 10.3233/RNN-150506.
    Results Reference
    result

    Learn more about this trial

    Telemedicine Program in Parkinson's Disease (TELEPARK)

    We'll reach out to this number within 24 hrs